| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |